SINOTHERAPEUTICS INC.

Altre lingue Sinotherapeutics Inc.

Azioni

688247

CNE100005PL9

Prezzo di chiusura Shanghai S.E. Altri mercati azionari 00:00:00 14/06/2024			Variaz. 5gg	Var. 1 gen.
8,65 ^CNY	-2,26%		+2,25%	-21,22%

29/04	Sinotherapeutics Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
23/02	Sinotherapeutics Inc. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Sinotherapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Tranche Update on Sinotherapeutics Inc.'s Equity Buyback Plan announced on February 21, 2024.	02/04
Sinotherapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	23/02
Sinotherapeutics Inc. announces an Equity Buyback for CNY 70 million worth of its shares.	21/02
Sinotherapeutics Inc. authorizes a Buyback Plan.	19/02
Sinotherapeutics Gets Nod for Mesalazine Tablets; Shares Drop 7%	05/02
Sinotherapeutics Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23
Sinotherapeutics' Unit Gets Registration Certificate for Sevelamer Carbonate Tablets	26/09/23
Sinotherapeutics Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	29/08/23
Sinotherapeutics Inc.(SHSE:688247) added to Shanghai Stock Exchange A Share Index	25/08/23
Sinotherapeutics Inc.(SHSE:688247) added to Shanghai Stock Exchange Composite Index	25/08/23
Sinotherapeutics Gets US FDA Nod for Arthritis Drug	10/08/23
Sinotherapeutics Signs Product Licensing Deal With US Drugmaker Lannett	07/08/23
FDA Greenlights Sinotherapeutics' Mesalazine Enteric-Coated Tablets	17/05/23
Sinotherapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/04/23
Sinotherapeutics Drug Selected in China's Centralized Drug Procurement	13/04/23
Sinotherapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23
Sinotherapeutics’ Antifungal Drug Added to China’s Medical Insurance Catalog	19/01/23
Sinotherapeutics Inc. has completed an IPO in the amount of CNY 424.8358 million.	22/08/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Assicura e Aumenta la Performance dei tuoi Investimenti con il nostro Team di Esperti al tuo fianco

Assicurare i miei Investimenti

fermer